Prot# C-447: A Phase I Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Assessment of CG53135-05 Administered Intravenously in Patients with Oral Mucositis After Receiving Autologous Stem Cell Transplant (Multiple Rising-Dose Tolera

Project: Research project

Project Details

StatusFinished
Effective start/end date4/15/05 → 9/30/09

Funding

  • Prologue Research International, Inc. (C-447 // C-447)
  • CuraGen Corporation (C-447 // C-447)